nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A8—choroid plexus—malignant glioma	0.0524	0.131	CbGeAlD
L-Carnitine—SLC25A29—telencephalon—malignant glioma	0.0156	0.039	CbGeAlD
L-Carnitine—CROT—telencephalon—malignant glioma	0.0143	0.0358	CbGeAlD
L-Carnitine—SLC25A29—medulla oblongata—malignant glioma	0.0123	0.0307	CbGeAlD
L-Carnitine—CRAT—telencephalon—malignant glioma	0.0121	0.0302	CbGeAlD
L-Carnitine—SLC25A29—midbrain—malignant glioma	0.0112	0.028	CbGeAlD
L-Carnitine—SLC25A29—spinal cord—malignant glioma	0.0109	0.0273	CbGeAlD
L-Carnitine—MPO—endothelium—malignant glioma	0.0103	0.0258	CbGeAlD
L-Carnitine—CROT—midbrain—malignant glioma	0.0103	0.0257	CbGeAlD
L-Carnitine—CPT2—retina—malignant glioma	0.0101	0.0253	CbGeAlD
L-Carnitine—CPT1A—telencephalon—malignant glioma	0.0098	0.0245	CbGeAlD
L-Carnitine—SLC25A20—medulla oblongata—malignant glioma	0.00979	0.0245	CbGeAlD
L-Carnitine—MPO—blood vessel—malignant glioma	0.00951	0.0237	CbGeAlD
L-Carnitine—CRAT—medulla oblongata—malignant glioma	0.0095	0.0237	CbGeAlD
L-Carnitine—SLC25A20—midbrain—malignant glioma	0.00895	0.0224	CbGeAlD
L-Carnitine—SLC25A29—central nervous system—malignant glioma	0.00888	0.0222	CbGeAlD
L-Carnitine—Myasthenia—Carmustine—malignant glioma	0.00883	0.0445	CcSEcCtD
L-Carnitine—SLC25A20—spinal cord—malignant glioma	0.00873	0.0218	CbGeAlD
L-Carnitine—CRAT—midbrain—malignant glioma	0.00868	0.0217	CbGeAlD
L-Carnitine—SLC25A29—cerebellum—malignant glioma	0.00868	0.0217	CbGeAlD
L-Carnitine—CRAT—spinal cord—malignant glioma	0.00847	0.0212	CbGeAlD
L-Carnitine—CROT—central nervous system—malignant glioma	0.00814	0.0203	CbGeAlD
L-Carnitine—CROT—cerebellum—malignant glioma	0.00796	0.0199	CbGeAlD
L-Carnitine—CPT2—medulla oblongata—malignant glioma	0.00731	0.0183	CbGeAlD
L-Carnitine—SLC25A20—central nervous system—malignant glioma	0.00708	0.0177	CbGeAlD
L-Carnitine—SLC25A29—brain—malignant glioma	0.00705	0.0176	CbGeAlD
L-Carnitine—SLC25A20—cerebellum—malignant glioma	0.00692	0.0173	CbGeAlD
L-Carnitine—CRAT—central nervous system—malignant glioma	0.00687	0.0172	CbGeAlD
L-Carnitine—CRAT—cerebellum—malignant glioma	0.00672	0.0168	CbGeAlD
L-Carnitine—CPT2—midbrain—malignant glioma	0.00668	0.0167	CbGeAlD
L-Carnitine—CPT2—spinal cord—malignant glioma	0.00651	0.0163	CbGeAlD
L-Carnitine—CROT—brain—malignant glioma	0.00646	0.0161	CbGeAlD
L-Carnitine—Accidental injury—Carmustine—malignant glioma	0.00627	0.0316	CcSEcCtD
L-Carnitine—SLC25A20—brain—malignant glioma	0.00562	0.014	CbGeAlD
L-Carnitine—Injection site reaction—Carmustine—malignant glioma	0.00552	0.0278	CcSEcCtD
L-Carnitine—CRAT—brain—malignant glioma	0.00546	0.0136	CbGeAlD
L-Carnitine—CPT1A—cerebellum—malignant glioma	0.00544	0.0136	CbGeAlD
L-Carnitine—CPT2—central nervous system—malignant glioma	0.00529	0.0132	CbGeAlD
L-Carnitine—CPT2—cerebellum—malignant glioma	0.00517	0.0129	CbGeAlD
L-Carnitine—CPT1A—brain—malignant glioma	0.00442	0.011	CbGeAlD
L-Carnitine—Injury—Carmustine—malignant glioma	0.00438	0.0221	CcSEcCtD
L-Carnitine—CPT2—brain—malignant glioma	0.0042	0.0105	CbGeAlD
L-Carnitine—Muscular weakness—Carmustine—malignant glioma	0.00355	0.0179	CcSEcCtD
L-Carnitine—Muscular weakness—Temozolomide—malignant glioma	0.00343	0.0173	CcSEcCtD
L-Carnitine—Choline—BCHE—malignant glioma	0.00335	1	CrCbGaD
L-Carnitine—Bronchitis—Temozolomide—malignant glioma	0.00324	0.0163	CcSEcCtD
L-Carnitine—MPO—spinal cord—malignant glioma	0.00323	0.00807	CbGeAlD
L-Carnitine—CES1—central nervous system—malignant glioma	0.00314	0.00784	CbGeAlD
L-Carnitine—Depression—Carmustine—malignant glioma	0.0031	0.0156	CcSEcCtD
L-Carnitine—Weight increased—Temozolomide—malignant glioma	0.00306	0.0154	CcSEcCtD
L-Carnitine—Renal failure—Carmustine—malignant glioma	0.00305	0.0154	CcSEcCtD
L-Carnitine—Weight decreased—Temozolomide—malignant glioma	0.00304	0.0153	CcSEcCtD
L-Carnitine—SLC22A5—retina—malignant glioma	0.00303	0.00757	CbGeAlD
L-Carnitine—Urinary tract infection—Carmustine—malignant glioma	0.00302	0.0152	CcSEcCtD
L-Carnitine—Depression—Temozolomide—malignant glioma	0.00299	0.0151	CcSEcCtD
L-Carnitine—SLC22A4—spinal cord—malignant glioma	0.00295	0.00737	CbGeAlD
L-Carnitine—Urinary tract infection—Temozolomide—malignant glioma	0.00292	0.0147	CcSEcCtD
L-Carnitine—Sinusitis—Temozolomide—malignant glioma	0.00282	0.0142	CcSEcCtD
L-Carnitine—Haemoglobin—Carmustine—malignant glioma	0.0028	0.0141	CcSEcCtD
L-Carnitine—Haemorrhage—Carmustine—malignant glioma	0.00279	0.014	CcSEcCtD
L-Carnitine—Oedema peripheral—Carmustine—malignant glioma	0.00275	0.0138	CcSEcCtD
L-Carnitine—Haemoglobin—Temozolomide—malignant glioma	0.00271	0.0136	CcSEcCtD
L-Carnitine—Haemorrhage—Temozolomide—malignant glioma	0.00269	0.0136	CcSEcCtD
L-Carnitine—Pharyngitis—Temozolomide—malignant glioma	0.00267	0.0135	CcSEcCtD
L-Carnitine—Oedema peripheral—Temozolomide—malignant glioma	0.00265	0.0134	CcSEcCtD
L-Carnitine—MPO—central nervous system—malignant glioma	0.00262	0.00655	CbGeAlD
L-Carnitine—Eye disorder—Carmustine—malignant glioma	0.00261	0.0131	CcSEcCtD
L-Carnitine—Eye disorder—Temozolomide—malignant glioma	0.00252	0.0127	CcSEcCtD
L-Carnitine—CES1—brain—malignant glioma	0.00249	0.00623	CbGeAlD
L-Carnitine—Arrhythmia—Carmustine—malignant glioma	0.00249	0.0125	CcSEcCtD
L-Carnitine—Angiopathy—Temozolomide—malignant glioma	0.00244	0.0123	CcSEcCtD
L-Carnitine—Back pain—Carmustine—malignant glioma	0.00235	0.0118	CcSEcCtD
L-Carnitine—SLC22A4—cerebellum—malignant glioma	0.00234	0.00584	CbGeAlD
L-Carnitine—Dysgeusia—Temozolomide—malignant glioma	0.0023	0.0116	CcSEcCtD
L-Carnitine—Back pain—Temozolomide—malignant glioma	0.00227	0.0114	CcSEcCtD
L-Carnitine—Anaemia—Carmustine—malignant glioma	0.00224	0.0113	CcSEcCtD
L-Carnitine—SLC22A5—medulla oblongata—malignant glioma	0.00219	0.00547	CbGeAlD
L-Carnitine—Anaemia—Temozolomide—malignant glioma	0.00217	0.0109	CcSEcCtD
L-Carnitine—Vertigo—Temozolomide—malignant glioma	0.00211	0.0106	CcSEcCtD
L-Carnitine—Convulsion—Carmustine—malignant glioma	0.0021	0.0106	CcSEcCtD
L-Carnitine—SLC22A8—central nervous system—malignant glioma	0.0021	0.00523	CbGeAlD
L-Carnitine—Hypertension—Carmustine—malignant glioma	0.0021	0.0106	CcSEcCtD
L-Carnitine—MPO—brain—malignant glioma	0.00208	0.0052	CbGeAlD
L-Carnitine—Palpitations—Temozolomide—malignant glioma	0.00207	0.0104	CcSEcCtD
L-Carnitine—Myalgia—Carmustine—malignant glioma	0.00207	0.0104	CcSEcCtD
L-Carnitine—Chest pain—Carmustine—malignant glioma	0.00207	0.0104	CcSEcCtD
L-Carnitine—Anxiety—Carmustine—malignant glioma	0.00206	0.0104	CcSEcCtD
L-Carnitine—Cough—Temozolomide—malignant glioma	0.00205	0.0103	CcSEcCtD
L-Carnitine—Convulsion—Temozolomide—malignant glioma	0.00203	0.0102	CcSEcCtD
L-Carnitine—Hypertension—Temozolomide—malignant glioma	0.00202	0.0102	CcSEcCtD
L-Carnitine—SLC22A5—midbrain—malignant glioma	0.002	0.005	CbGeAlD
L-Carnitine—Myalgia—Temozolomide—malignant glioma	0.002	0.0101	CcSEcCtD
L-Carnitine—Anxiety—Temozolomide—malignant glioma	0.00199	0.01	CcSEcCtD
L-Carnitine—Infection—Carmustine—malignant glioma	0.00197	0.00991	CcSEcCtD
L-Carnitine—SLC22A5—spinal cord—malignant glioma	0.00195	0.00488	CbGeAlD
L-Carnitine—Tachycardia—Carmustine—malignant glioma	0.00193	0.00973	CcSEcCtD
L-Carnitine—Infection—Temozolomide—malignant glioma	0.0019	0.00958	CcSEcCtD
L-Carnitine—SLC22A4—brain—malignant glioma	0.0019	0.00475	CbGeAlD
L-Carnitine—Anorexia—Carmustine—malignant glioma	0.00189	0.00951	CcSEcCtD
L-Carnitine—Hypotension—Carmustine—malignant glioma	0.00185	0.00932	CcSEcCtD
L-Carnitine—Anorexia—Temozolomide—malignant glioma	0.00182	0.00919	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0018	0.00909	CcSEcCtD
L-Carnitine—Insomnia—Carmustine—malignant glioma	0.00179	0.00902	CcSEcCtD
L-Carnitine—Paraesthesia—Carmustine—malignant glioma	0.00178	0.00896	CcSEcCtD
L-Carnitine—Dyspnoea—Carmustine—malignant glioma	0.00177	0.00889	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00174	0.00878	CcSEcCtD
L-Carnitine—Insomnia—Temozolomide—malignant glioma	0.00173	0.00872	CcSEcCtD
L-Carnitine—Decreased appetite—Carmustine—malignant glioma	0.00172	0.00867	CcSEcCtD
L-Carnitine—Paraesthesia—Temozolomide—malignant glioma	0.00172	0.00865	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00171	0.00861	CcSEcCtD
L-Carnitine—Dyspnoea—Temozolomide—malignant glioma	0.00171	0.00859	CcSEcCtD
L-Carnitine—Constipation—Carmustine—malignant glioma	0.00169	0.00853	CcSEcCtD
L-Carnitine—Pain—Carmustine—malignant glioma	0.00169	0.00853	CcSEcCtD
L-Carnitine—Dyspepsia—Temozolomide—malignant glioma	0.00168	0.00848	CcSEcCtD
L-Carnitine—Decreased appetite—Temozolomide—malignant glioma	0.00166	0.00838	CcSEcCtD
L-Carnitine—SLC22A8—brain—malignant glioma	0.00166	0.00416	CbGeAlD
L-Carnitine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00165	0.00832	CcSEcCtD
L-Carnitine—Pain—Temozolomide—malignant glioma	0.00164	0.00824	CcSEcCtD
L-Carnitine—Constipation—Temozolomide—malignant glioma	0.00164	0.00824	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Carmustine—malignant glioma	0.00162	0.00816	CcSEcCtD
L-Carnitine—Abdominal pain—Carmustine—malignant glioma	0.00157	0.00788	CcSEcCtD
L-Carnitine—Body temperature increased—Carmustine—malignant glioma	0.00157	0.00788	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00157	0.00788	CcSEcCtD
L-Carnitine—SLC22A5—cerebellum—malignant glioma	0.00155	0.00387	CbGeAlD
L-Carnitine—Body temperature increased—Temozolomide—malignant glioma	0.00151	0.00762	CcSEcCtD
L-Carnitine—Abdominal pain—Temozolomide—malignant glioma	0.00151	0.00762	CcSEcCtD
L-Carnitine—Hypersensitivity—Carmustine—malignant glioma	0.00146	0.00735	CcSEcCtD
L-Carnitine—Asthenia—Carmustine—malignant glioma	0.00142	0.00716	CcSEcCtD
L-Carnitine—Hypersensitivity—Temozolomide—malignant glioma	0.00141	0.0071	CcSEcCtD
L-Carnitine—Asthenia—Temozolomide—malignant glioma	0.00137	0.00692	CcSEcCtD
L-Carnitine—Diarrhoea—Carmustine—malignant glioma	0.00136	0.00682	CcSEcCtD
L-Carnitine—Pruritus—Temozolomide—malignant glioma	0.00135	0.00682	CcSEcCtD
L-Carnitine—Dizziness—Carmustine—malignant glioma	0.00131	0.0066	CcSEcCtD
L-Carnitine—Diarrhoea—Temozolomide—malignant glioma	0.00131	0.00659	CcSEcCtD
L-Carnitine—Dizziness—Temozolomide—malignant glioma	0.00127	0.00637	CcSEcCtD
L-Carnitine—Vomiting—Carmustine—malignant glioma	0.00126	0.00634	CcSEcCtD
L-Carnitine—SLC22A5—brain—malignant glioma	0.00126	0.00314	CbGeAlD
L-Carnitine—Rash—Carmustine—malignant glioma	0.00125	0.00629	CcSEcCtD
L-Carnitine—Dermatitis—Carmustine—malignant glioma	0.00125	0.00628	CcSEcCtD
L-Carnitine—Headache—Carmustine—malignant glioma	0.00124	0.00625	CcSEcCtD
L-Carnitine—Vomiting—Temozolomide—malignant glioma	0.00122	0.00613	CcSEcCtD
L-Carnitine—Rash—Temozolomide—malignant glioma	0.00121	0.00608	CcSEcCtD
L-Carnitine—Dermatitis—Temozolomide—malignant glioma	0.00121	0.00607	CcSEcCtD
L-Carnitine—Headache—Temozolomide—malignant glioma	0.0012	0.00604	CcSEcCtD
L-Carnitine—Nausea—Carmustine—malignant glioma	0.00118	0.00592	CcSEcCtD
L-Carnitine—Nausea—Temozolomide—malignant glioma	0.00114	0.00573	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000658	0.00165	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IL1B—malignant glioma	0.000653	0.00164	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IFNG—malignant glioma	0.00064	0.00161	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS1—malignant glioma	0.000636	0.0016	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—MYC—malignant glioma	0.000635	0.0016	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000634	0.00159	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00063	0.00158	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000613	0.00154	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000613	0.00154	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000613	0.00154	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—PPARG—malignant glioma	0.000608	0.00153	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—COX8A—malignant glioma	0.000607	0.00153	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000602	0.00151	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.0006	0.00151	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TNF—malignant glioma	0.000596	0.0015	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000595	0.0015	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000592	0.00149	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000592	0.00149	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—BCHE—malignant glioma	0.000592	0.00149	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SLC5A5—malignant glioma	0.000584	0.00147	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTT1—malignant glioma	0.000577	0.00145	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTT1—malignant glioma	0.000577	0.00145	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL1B—malignant glioma	0.000571	0.00143	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000568	0.00143	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—AKT1—malignant glioma	0.000565	0.00142	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—IDH2—malignant glioma	0.000564	0.00142	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000553	0.00139	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000548	0.00138	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000545	0.00137	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000544	0.00137	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000544	0.00137	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000543	0.00136	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS1—malignant glioma	0.000541	0.00136	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS1—malignant glioma	0.000541	0.00136	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000539	0.00136	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000539	0.00136	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000532	0.00134	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP2B6—malignant glioma	0.000531	0.00133	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—malignant glioma	0.000528	0.00133	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000526	0.00132	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—malignant glioma	0.000526	0.00132	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ASMT—malignant glioma	0.000516	0.0013	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—APOD—malignant glioma	0.000512	0.00129	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000504	0.00127	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—BCHE—malignant glioma	0.000503	0.00126	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—BCHE—malignant glioma	0.000503	0.00126	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SLC5A5—malignant glioma	0.000497	0.00125	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SLC5A5—malignant glioma	0.000497	0.00125	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—KRAS—malignant glioma	0.000488	0.00123	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—BCAN—malignant glioma	0.000485	0.00122	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—IDH1—malignant glioma	0.000485	0.00122	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000478	0.0012	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000476	0.0012	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—malignant glioma	0.000474	0.00119	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000473	0.00119	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTP1—malignant glioma	0.000471	0.00118	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00047	0.00118	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00047	0.00118	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SPHK1—malignant glioma	0.00047	0.00118	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000466	0.00117	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000466	0.00117	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—APOD—malignant glioma	0.000463	0.00116	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000461	0.00116	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP2C18—malignant glioma	0.00046	0.00116	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CAT—malignant glioma	0.000458	0.00115	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000452	0.00114	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000451	0.00113	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000434	0.00109	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—NCOR1—malignant glioma	0.000433	0.00109	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000428	0.00108	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—PTEN—malignant glioma	0.000417	0.00105	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—malignant glioma	0.000414	0.00104	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000413	0.00104	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000408	0.00102	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000406	0.00102	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000406	0.00102	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—COX8A—malignant glioma	0.000402	0.00101	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTP1—malignant glioma	0.0004	0.00101	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTP1—malignant glioma	0.0004	0.00101	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000395	0.000994	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000395	0.000993	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—IDH2—malignant glioma	0.000391	0.000983	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CAT—malignant glioma	0.000389	0.000979	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CAT—malignant glioma	0.000389	0.000979	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000381	0.000959	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000373	0.000938	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTT1—malignant glioma	0.000372	0.000935	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000369	0.000927	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—RTEL1—malignant glioma	0.000368	0.000926	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NCOR1—malignant glioma	0.000368	0.000925	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NCOR1—malignant glioma	0.000368	0.000925	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP2B6—malignant glioma	0.000368	0.000925	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000361	0.000908	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CAV1—malignant glioma	0.000353	0.000886	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000351	0.000883	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS1—malignant glioma	0.000349	0.000876	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000349	0.000876	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000347	0.000873	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ASMT—malignant glioma	0.000342	0.000859	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000337	0.000847	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—IDH1—malignant glioma	0.000336	0.000846	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SPHK1—malignant glioma	0.000325	0.000818	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000325	0.000817	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—BCHE—malignant glioma	0.000324	0.000815	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BCAN—malignant glioma	0.000321	0.000808	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CG—malignant glioma	0.000321	0.000807	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC5A5—malignant glioma	0.00032	0.000805	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00032	0.000805	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP2C18—malignant glioma	0.000319	0.000802	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PPARG—malignant glioma	0.00031	0.000779	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000309	0.000778	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000305	0.000766	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000303	0.000761	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000301	0.000756	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.0003	0.000754	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CAV1—malignant glioma	0.0003	0.000754	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CAV1—malignant glioma	0.0003	0.000754	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000286	0.00072	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000286	0.00072	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—malignant glioma	0.000285	0.000715	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CD—malignant glioma	0.000282	0.00071	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000274	0.000689	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CG—malignant glioma	0.000273	0.000686	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CG—malignant glioma	0.000273	0.000686	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000264	0.000665	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PPARG—malignant glioma	0.000264	0.000663	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPARG—malignant glioma	0.000264	0.000663	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000263	0.000662	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000262	0.000659	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000262	0.000658	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—IDH2—malignant glioma	0.000259	0.000651	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTT1—malignant glioma	0.000258	0.000648	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTP1—malignant glioma	0.000258	0.000648	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000255	0.000641	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CAT—malignant glioma	0.000251	0.000631	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CB—malignant glioma	0.000246	0.000619	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS2—malignant glioma	0.000244	0.000613	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2B6—malignant glioma	0.000244	0.000612	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS1—malignant glioma	0.000242	0.000607	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000241	0.000605	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000241	0.000605	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CD—malignant glioma	0.00024	0.000603	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CD—malignant glioma	0.00024	0.000603	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NCOR1—malignant glioma	0.000237	0.000596	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000237	0.000596	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000229	0.000576	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—BCHE—malignant glioma	0.000225	0.000565	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—IDH1—malignant glioma	0.000223	0.00056	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC5A5—malignant glioma	0.000222	0.000558	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000218	0.000547	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SPHK1—malignant glioma	0.000216	0.000542	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—malignant glioma	0.000213	0.000535	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—COX8A—malignant glioma	0.000212	0.000532	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2C18—malignant glioma	0.000211	0.000531	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00021	0.000528	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CB—malignant glioma	0.000209	0.000526	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CB—malignant glioma	0.000209	0.000526	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000208	0.000523	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—malignant glioma	0.000207	0.000521	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—malignant glioma	0.000207	0.000521	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000207	0.000521	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CAV1—malignant glioma	0.000193	0.000486	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000189	0.000476	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000185	0.000464	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000181	0.000456	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—malignant glioma	0.000181	0.000455	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—malignant glioma	0.000181	0.000455	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ASMT—malignant glioma	0.00018	0.000452	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00018	0.000452	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—malignant glioma	0.000179	0.000449	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—malignant glioma	0.000176	0.000442	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000176	0.000442	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAT—malignant glioma	0.000174	0.000437	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—malignant glioma	0.000171	0.000429	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARG—malignant glioma	0.00017	0.000427	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BCAN—malignant glioma	0.000169	0.000425	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000165	0.000415	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NCOR1—malignant glioma	0.000164	0.000413	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS1—malignant glioma	0.00016	0.000402	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000157	0.000395	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CD—malignant glioma	0.000155	0.000389	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—malignant glioma	0.00015	0.000377	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BCHE—malignant glioma	0.000149	0.000374	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC5A5—malignant glioma	0.000147	0.00037	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000138	0.000347	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—IDH2—malignant glioma	0.000136	0.000343	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CB—malignant glioma	0.000135	0.000339	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAV1—malignant glioma	0.000134	0.000337	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—malignant glioma	0.000134	0.000336	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000129	0.000323	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2B6—malignant glioma	0.000128	0.000322	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000128	0.000322	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—malignant glioma	0.000128	0.000321	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—malignant glioma	0.000128	0.000321	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—malignant glioma	0.000123	0.000308	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—malignant glioma	0.000122	0.000307	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—malignant glioma	0.000118	0.000298	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARG—malignant glioma	0.000118	0.000296	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—IDH1—malignant glioma	0.000117	0.000295	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—malignant glioma	0.000117	0.000293	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAT—malignant glioma	0.000115	0.00029	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SPHK1—malignant glioma	0.000113	0.000285	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2C18—malignant glioma	0.000111	0.000279	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOR1—malignant glioma	0.000109	0.000274	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CD—malignant glioma	0.000107	0.00027	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000105	0.000264	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—malignant glioma	0.000104	0.000262	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—malignant glioma	0.000104	0.000262	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000104	0.000261	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.55e-05	0.00024	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	9.39e-05	0.000236	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CB—malignant glioma	9.35e-05	0.000235	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—malignant glioma	9.26e-05	0.000233	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.22e-05	0.000232	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—malignant glioma	8.99e-05	0.000226	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAV1—malignant glioma	8.87e-05	0.000223	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS1—malignant glioma	8.43e-05	0.000212	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.39e-05	0.000211	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—malignant glioma	8.22e-05	0.000207	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—malignant glioma	8.08e-05	0.000203	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—malignant glioma	8.08e-05	0.000203	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BCHE—malignant glioma	7.83e-05	0.000197	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARG—malignant glioma	7.8e-05	0.000196	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A5—malignant glioma	7.74e-05	0.000194	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.32e-05	0.000184	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.25e-05	0.000182	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.13e-05	0.000179	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CD—malignant glioma	7.1e-05	0.000179	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—malignant glioma	6.72e-05	0.000169	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.32e-05	0.000159	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—malignant glioma	6.23e-05	0.000157	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CB—malignant glioma	6.19e-05	0.000156	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—malignant glioma	6.13e-05	0.000154	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAT—malignant glioma	6.06e-05	0.000152	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOR1—malignant glioma	5.73e-05	0.000144	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—malignant glioma	5.7e-05	0.000143	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—malignant glioma	5.35e-05	0.000134	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAV1—malignant glioma	4.67e-05	0.000117	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—malignant glioma	4.65e-05	0.000117	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.46e-05	0.000112	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—malignant glioma	4.25e-05	0.000107	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARG—malignant glioma	4.1e-05	0.000103	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—malignant glioma	3.77e-05	9.49e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CD—malignant glioma	3.74e-05	9.4e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CB—malignant glioma	3.26e-05	8.19e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—malignant glioma	3.23e-05	8.12e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—malignant glioma	3.08e-05	7.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—malignant glioma	2.82e-05	7.08e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.99e-05	4.99e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—malignant glioma	1.62e-05	4.08e-05	CbGpPWpGaD
